BibTex RIS Kaynak Göster

Natriüretik Peptidler

Yıl 2005, Cilt: 62 Sayı: 1, 49 - 54, 01.06.2005

Fatma Uçar Serpil Turhan

Öz

Nörohormonların kalp yetmezliği olan hastaların dolaşımına salındığı ve aktive olduğu iyi bilinmesine rağmen terapötik önemi ancak geçtiğimiz 10-15 yıl içinde ortaya çıkmıştır. Vücut, simpatik sinir sistemi ve renin-anjiotensin sisteminden salınan vazokonstriktör nörohormonların etkisine karşı, vazodilatatör antiproliferatif natriüretik peptidler üretir. Homeostazisi sağlamak amacıyla üretilen bu peptidler, dolaşımda ve kalp yetmezliğinde önemli rol oynamaktadırlar 1 .

Kaynakça

  • 1. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. The European Journal of Heart Failure 2004; 6, 261-8.
  • 2. Iida T, Hirata Y, Takemura N, Togashi K, Nakagawa S, Marumo F. Brain natriuretic peptide is cosecreted with atrial natriuretic peptide from porcine cardiocytes. Federation of European Biochemical Societies 1990; 260 (1), 98-100.
  • 3. Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Hom Metab Res 1999; 31:487-98.
  • 4. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure Endocr Rev 2003; 24: 341-56.
  • 5. Mair J, Hammerer-Lercher A, Puchendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chim Lab Med 2001; 39: 571-88.
  • 6. Maisel A. B-type natriuretic peptide levels:a potential novel ‘white count’ for congestive heart failure J Cardiac Failure. 2001; 7: 183-93.
  • 7. Wijeyaratne CN, Moult P JA. The effect of á human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. Journal of Clinical Endocrinology and Metabolism. 1993; 76, 343-6.
  • 8. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increasad plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993; 88, 82-91.
  • 9. Yasue H, Obata K, Okumura K. et al. Increased secretion of atrial natriuretic polypeptide from the left ventricule in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51.
  • 10. Saito Y, Nakao K, Arai H. et al. Augmented expression of atrial natriuretic polypeptide gene in ventricule of human failing heart. J Clin Invest 1989; 83: 298-305.
  • 11. Hall C. Essential biochemistry and physiology (NT-pro) BNP. The European Journal of Heart Failure. 2004; 6: 257-60.
  • 12. De Denus S, Pharand C, Williamson D R. Brain natriuretic peptide in the management of heart failure. Chest. 2004; 125: 652-68.
  • 13.Wu AHB, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. The European Journal of Heart Failure. 2004; 6: 355-8.
  • 14. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute mjocardial infarction. Circulation. 1995; 92: 1558-64.
  • 15. Richards AM, Lainchbury JG, Nicholis MG, Cameron AV, Yandle TG. Dendroaspis natriuretic peptide: endogenous or dubious?. Lancet 2002; 359: 5-6.
  • 16. McCullough PA, Joseph K, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev. Cardiovasc. Med. 2004; 5(1): 16-25.
  • 17. Burrell LM, Lambert HJ, Baylis P H. Effect of atrial natriüretic peptide on thirst and arginine vasopressin release in humans. Am J Physiol 1991; 260: 475-9.
  • 18. Steele MK, Gardner DG, Xie PL. et al. Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow. Am J Physiol 1991; 260: 1145-51.
  • 19. Panteghini M. Role and importance of biochemical markers in clinical cardiology. European Heart Journal. 2004; 25: 1187-96.
  • 20. Talwar S, Squire IB, Downie PF, McCullough AM, Campton MC, Davies JE, Barnett DB, Ng LL. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. European Heart Journal. 2000; 21: 1514-21.
  • 21. Wiviott SD, De Lemos JA, Morrow DA. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clinica Chimica Acta. 2004; 346: 119-28.
  • 22. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson P, Sutherland P, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002; 9: 254-8.

Natriuretıc Peptides

Yıl 2005, Cilt: 62 Sayı: 1, 49 - 54, 01.06.2005

Fatma Uçar Serpil Turhan

Öz

Kaynakça

  • 1. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. The European Journal of Heart Failure 2004; 6, 261-8.
  • 2. Iida T, Hirata Y, Takemura N, Togashi K, Nakagawa S, Marumo F. Brain natriuretic peptide is cosecreted with atrial natriuretic peptide from porcine cardiocytes. Federation of European Biochemical Societies 1990; 260 (1), 98-100.
  • 3. Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Hom Metab Res 1999; 31:487-98.
  • 4. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure Endocr Rev 2003; 24: 341-56.
  • 5. Mair J, Hammerer-Lercher A, Puchendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chim Lab Med 2001; 39: 571-88.
  • 6. Maisel A. B-type natriuretic peptide levels:a potential novel ‘white count’ for congestive heart failure J Cardiac Failure. 2001; 7: 183-93.
  • 7. Wijeyaratne CN, Moult P JA. The effect of á human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. Journal of Clinical Endocrinology and Metabolism. 1993; 76, 343-6.
  • 8. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K. Increasad plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993; 88, 82-91.
  • 9. Yasue H, Obata K, Okumura K. et al. Increased secretion of atrial natriuretic polypeptide from the left ventricule in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46-51.
  • 10. Saito Y, Nakao K, Arai H. et al. Augmented expression of atrial natriuretic polypeptide gene in ventricule of human failing heart. J Clin Invest 1989; 83: 298-305.
  • 11. Hall C. Essential biochemistry and physiology (NT-pro) BNP. The European Journal of Heart Failure. 2004; 6: 257-60.
  • 12. De Denus S, Pharand C, Williamson D R. Brain natriuretic peptide in the management of heart failure. Chest. 2004; 125: 652-68.
  • 13.Wu AHB, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. The European Journal of Heart Failure. 2004; 6: 355-8.
  • 14. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute mjocardial infarction. Circulation. 1995; 92: 1558-64.
  • 15. Richards AM, Lainchbury JG, Nicholis MG, Cameron AV, Yandle TG. Dendroaspis natriuretic peptide: endogenous or dubious?. Lancet 2002; 359: 5-6.
  • 16. McCullough PA, Joseph K, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev. Cardiovasc. Med. 2004; 5(1): 16-25.
  • 17. Burrell LM, Lambert HJ, Baylis P H. Effect of atrial natriüretic peptide on thirst and arginine vasopressin release in humans. Am J Physiol 1991; 260: 475-9.
  • 18. Steele MK, Gardner DG, Xie PL. et al. Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow. Am J Physiol 1991; 260: 1145-51.
  • 19. Panteghini M. Role and importance of biochemical markers in clinical cardiology. European Heart Journal. 2004; 25: 1187-96.
  • 20. Talwar S, Squire IB, Downie PF, McCullough AM, Campton MC, Davies JE, Barnett DB, Ng LL. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. European Heart Journal. 2000; 21: 1514-21.
  • 21. Wiviott SD, De Lemos JA, Morrow DA. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clinica Chimica Acta. 2004; 346: 119-28.
  • 22. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson P, Sutherland P, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002; 9: 254-8.
Toplam 22 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Derleme
Yazarlar

Fatma Uçar Bu kişi benim

Serpil Turhan Bu kişi benim

Yayımlanma Tarihi 1 Haziran 2005
Yayımlandığı Sayı Yıl 2005 Cilt: 62 Sayı: 1

Kaynak Göster

APA Uçar, F., & Turhan, S. (2005). Natriüretik Peptidler. Türk Hijyen Ve Deneysel Biyoloji Dergisi, 62(1), 49-54.
AMA Uçar F, Turhan S. Natriüretik Peptidler. Turk Hij Den Biyol Derg. Haziran 2005;62(1):49-54.
Chicago Uçar, Fatma, ve Serpil Turhan. “Natriüretik Peptidler”. Türk Hijyen Ve Deneysel Biyoloji Dergisi 62, sy. 1 (Haziran 2005): 49-54.
EndNote Uçar F, Turhan S (01 Haziran 2005) Natriüretik Peptidler. Türk Hijyen ve Deneysel Biyoloji Dergisi 62 1 49–54.
IEEE F. Uçar ve S. Turhan, “Natriüretik Peptidler”, Turk Hij Den Biyol Derg, c. 62, sy. 1, ss. 49–54, 2005.
ISNAD Uçar, Fatma - Turhan, Serpil. “Natriüretik Peptidler”. Türk Hijyen ve Deneysel Biyoloji Dergisi 62/1 (Haziran 2005), 49-54.
JAMA Uçar F, Turhan S. Natriüretik Peptidler. Turk Hij Den Biyol Derg. 2005;62:49–54.
MLA Uçar, Fatma ve Serpil Turhan. “Natriüretik Peptidler”. Türk Hijyen Ve Deneysel Biyoloji Dergisi, c. 62, sy. 1, 2005, ss. 49-54.
Vancouver Uçar F, Turhan S. Natriüretik Peptidler. Turk Hij Den Biyol Derg. 2005;62(1):49-54.